论文部分内容阅读
目的 观察普伐他汀与卡托普利治疗高脂血症的协同作用。方法 选择 10 4例高脂血症患者作为治疗组 ,与同期 10 4例作为对照组进行 3个月、6个月临床观察血脂水平的变化。结果 治疗组血脂下降明显 ,特别是对高TC ,高LDL -c降低作用明显 ,随疗程延长 ,治疗组更趋明显P <0 .0 5。结论 普伐他汀与卡托普利治疗高脂血症使血脂下降明显 ,且具有协同作用 ,减少了心血管疾病的发生率
Objective To observe the synergistic effect of pravastatin and captopril on hyperlipidemia. Methods A total of 104 patients with hyperlipidemia were selected as the treatment group, and 10 4 patients in the same period were selected as the control group for 3 months and 6 months of clinical observation of blood lipid levels. Results In the treatment group, the decline of blood lipid was obvious, especially for the reduction of high TC and high LDL-c. With the prolongation of treatment, the treatment group was more obvious P <0. Conclusion Pravastatin and captopril treatment of hyperlipidemia significantly decreased blood lipids, and has a synergistic effect, reducing the incidence of cardiovascular disease